203 related articles for article (PubMed ID: 1396587)
1. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.
Renshaw MW; Kipreos ET; Albrecht MR; Wang JY
EMBO J; 1992 Nov; 11(11):3941-51. PubMed ID: 1396587
[TBL] [Abstract][Full Text] [Related]
2. Rac is required for v-Abl tyrosine kinase to activate mitogenesis.
Renshaw MW; Lea-Chou E; Wang JY
Curr Biol; 1996 Jan; 6(1):76-83. PubMed ID: 8805224
[TBL] [Abstract][Full Text] [Related]
3. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
Chen YY; Rosenberg N
Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
[TBL] [Abstract][Full Text] [Related]
4. Cells arrested in G1 by the v-Abl tyrosine kinase do not express cyclin A despite the hyperphosphorylation of RB.
Chen Y; Knudsen ES; Wang JY
J Biol Chem; 1996 Aug; 271(33):19637-40. PubMed ID: 8702661
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
Evans CA; Owen-Lynch PJ; Whetton AD; Dive C
Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488
[TBL] [Abstract][Full Text] [Related]
6. A novel mutation within the kinase domain of v-abl gene responsible for temperature-sensitive colony-forming ability in soft agar.
Soma T; Tsukada S; Oka Y; Kishimoto T; Sugiyama H
Virology; 1993 Apr; 193(2):967-70. PubMed ID: 8460498
[TBL] [Abstract][Full Text] [Related]
7. The human leukemia oncogene bcr-abl abrogates the anchorage requirement but not the growth factor requirement for proliferation.
Renshaw MW; McWhirter JR; Wang JY
Mol Cell Biol; 1995 Mar; 15(3):1286-93. PubMed ID: 7862122
[TBL] [Abstract][Full Text] [Related]
8. v-Abl activates c-myc transcription through the E2F site.
Wong KK; Zou X; Merrell KT; Patel AJ; Marcu KB; Chellappan S; Calame K
Mol Cell Biol; 1995 Dec; 15(12):6535-44. PubMed ID: 8524218
[TBL] [Abstract][Full Text] [Related]
9. The carboxyl terminus of v-Abl protein can augment SH2 domain function.
Warren D; Heilpern AJ; Berg K; Rosenberg N
J Virol; 2000 May; 74(10):4495-504. PubMed ID: 10775585
[TBL] [Abstract][Full Text] [Related]
10. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene.
Jacobsen EA; Ananieva O; Brown ML; Chang Y
J Immunol; 2006 Jun; 176(11):6831-8. PubMed ID: 16709843
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Abelson oncogene function by erbstatin analogues.
Kawada M; Tawara J; Tsuji T; Honma Y; Hozumi M; Wang JY; Umezawa K
Drugs Exp Clin Res; 1993; 19(6):235-41. PubMed ID: 8013266
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of v-Abl transformation by p53 and p19ARF.
Cong F; Zou X; Hinrichs K; Calame K; Goff SP
Oncogene; 1999 Dec; 18(54):7731-9. PubMed ID: 10618713
[TBL] [Abstract][Full Text] [Related]
13. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
[TBL] [Abstract][Full Text] [Related]
14. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Chen YY; Wang LC; Huang MS; Rosenberg N
Genes Dev; 1994 Mar; 8(6):688-97. PubMed ID: 7926759
[TBL] [Abstract][Full Text] [Related]
15. Characterization of flat revertants isolated from cells transformed by Abelson murine leukemia virus (Ab-MuLV).
Oka T; Yutsudo M; Inoue H; Higuchi F; Hakura A
J Cell Physiol; 1990 Dec; 145(3):428-33. PubMed ID: 1703165
[TBL] [Abstract][Full Text] [Related]
16. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction.
Raffel GD; Parmar K; Rosenberg N
J Biol Chem; 1996 Mar; 271(9):4640-5. PubMed ID: 8617726
[TBL] [Abstract][Full Text] [Related]
17. Transforming pathways activated by the v-Abl tyrosine kinase.
Shore SK; Tantravahi RV; Reddy EP
Oncogene; 2002 Dec; 21(56):8568-76. PubMed ID: 12476303
[TBL] [Abstract][Full Text] [Related]
18. v-Abl-mediated apoptotic suppression is associated with SHC phosphorylation without concomitant mitogen-activated protein kinase activation.
Owen-Lynch PJ; Wong AK; Whetton AD
J Biol Chem; 1995 Mar; 270(11):5956-62. PubMed ID: 7534303
[TBL] [Abstract][Full Text] [Related]
19. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
Engelman A; Rosenberg N
J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
[TBL] [Abstract][Full Text] [Related]
20. Reversible dependence on growth factor interleukin-3 in myeloid cells expressing temperature sensitive v-abl oncogene.
Kipreos ET; Wang JY
Oncogene Res; 1988 Feb; 2(3):277-84. PubMed ID: 3259302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
